Number of PSMA-PET positive lymph nodes affects outcome in node positive prostate cancer patients

被引：0
|
作者：
Spohn, S. [1 ,2 ,3 ]
Birkenmaier, V. [1 ]
Ruf, J. [4 ]
Sprave, T. [1 ,2 ]
Grosu, A. [1 ,2 ]
Zamboglou, C. [1 ,2 ,3 ,5 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany
[2] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany
[3] Univ Freiburg, Berta Ottenstein Programme, Fac Med, Freiburg, Germany
[4] Univ Med Ctr Freiburg, Dept Nucl Med, Freiburg, Germany
[5] European Univ Cyprus, German Oncol Ctr, Limassol, Cyprus
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1411
引用
收藏
页码：S1196 / S1197
页数：2
相关论文
共 50 条
  • [1] Radiotherapy for node-positive prostate cancer in the PSMA-PET era: The need for prospective clinical trials
    Ong, Wee Loon
    Kang, Therese Min Jung
    Loblaw, Andrew
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2025, 69 (01) : 126 - 128
  • [2] THE NUMBER OF POSITIVE LYMPH NODES AFFECTS CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH NODE-POSITIVE RENAL CELL CARCINOMA
    Roscigno, M.
    Bertini, R.
    Strada, E.
    Petralia, G.
    Volpe, A.
    Scattoni, V
    Angiolilli, D.
    Matloob, R.
    Sozzi, F.
    Gallina, A.
    Terrone, C.
    Montorsi, F.
    Rigatti, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 181 - 181
  • [3] HEAD-TO-HEAD COMPARISON OF LYMPH NODE DENSITY AND NUMBER OF POSITIVE LYMPH NODES IN STRATIFYING THE OUTCOME OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER SUBMITTED TO RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION
    Passoni, Niccolo Maria
    Bianchi, Marco
    Abdollah, Firas
    Gallina, Andrea
    Suardi, Nazareno
    Matloob, Rayan
    Tutolo, Manuela
    Fossati, Nicola
    Zanni, Giuseppe Emilio
    Colombo, Renzo
    Cozzarini, Cesare
    Salonia, Andrea
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2013, 189 (04): : E318 - E319
  • [4] Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection
    Passoni, Niccolo Maria
    Abdollah, Firas
    Suardi, Nazareno
    Gallina, Andrea
    Bianchi, Marco
    Tutolo, Manuela
    Fossati, Nicola
    Gandaglia, Giorgio
    Salonia, Andrea
    Freschi, Massimo
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 29.e21 - 29.e28
  • [5] Prospective evaluation of PSMA-PET imaging for preoperative lymph node staging in prostate cancer
    Eiber, Matthias
    Maurer, Tobias
    Beer, Ambros
    Souvatzoglou, Michael
    Weirich, Gregor
    Kuebler, Hubert
    Gschwend, Juergen
    Wester, Hans
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [6] Outcomes & predictors of progression: SBRT for lymph node oligorecurrent prostate cancer on PSMA-PET
    Werensteijn-Honingh, A.
    Wevers, A.
    Peters, M.
    Kroon, P.
    Intven, M.
    Eppinga, W.
    Jurgenliemk-Schulz, I.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S573 - S575
  • [7] The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer Comment
    Kalampokis, Nikolaos
    Grivas, Nikolaos
    GLAND SURGERY, 2020, 9 (04) : 1080 - 1081
  • [8] Is expanded radiographic criteria for clinically positive lymph nodes associated with outcome in pathologically node positive prostate cancer?
    Reichard, Chad A.
    Gregg, Justin
    Bathala, Tharakeswara
    Achim, Mary F.
    Davis, John W.
    Chapin, Brian Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] Prediction of pelvic lymph node metastases and PSMA PET positive pelvic lymph nodes with multiparametric MRI and clinical information in primary staging of prostate cancer
    Hotker, Andreas M.
    Muhlematter, Urs
    Beintner-Skawran, Stephan
    Ghafoor, Soleen
    Burger, Irene
    Huellner, Martin
    Eberli, Daniel
    Donati, Olivio F.
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2023, 10
  • [10] Validation of gallium-68 PSMA-PET/CT for primary lymph node staging in prostate cancer patients
    van Kalmthout, L.
    van Melick, H.
    Lavalaye, J.
    Meijer, R.
    Kooistra, A.
    de Klerk, J.
    Braat, A.
    Kaldeway, P.
    de Keizer, B.
    Lam, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S295 - S295
12345